Soaring costs of cancer care gives little pain relief to patients

12 October 2008

MediCare International, a private medical health care provider, has uncovered exactly what it costs for an average cancer patient in western Europe. With the proliferation of new expensive cancer treatments on the market, coupled with government's being unable to fund the specific needs of each patient on a case-by-case basis, costs are becoming prohibitive without the correct insurance.

Taking breast cancer as an example, it notes that western society has the highest rate of the disease; according to the World Health Organization, one in 16 women in western Europe will be affected by breast cancer. In the UK, nearly 46,000 are diagnosed with breast cancer each year, and more than 1,000 women die of the disease each month.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight